Cambridge Investment Research Advisors
STJ

Cambridge Investment Research Advisors’s St Jude Medical STJ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,675
Closed -$615K – 1846
2016
Q4 		$615K Sell
7,675
-228
-3% -$18.1K 0.01% 916
2016
Q3 		$630K Sell
7,903
-8,168
-51% -$659K 0.01% 918
2016
Q2 		$1.25M Sell
16,071
-6,962
-30% -$496K 0.03% 512
2016
Q1 		$1.27M Sell
23,033
-593
-3% -$32.3K 0.03% 481
2015
Q4 		$1.46M Buy
23,626
+6,157
+35% +$388K 0.03% 432
2015
Q3 		$1.1M Buy
17,469
+9,410
+117% +$672K 0.03% 451
2015
Q2 		$589K Sell
8,059
-515
-6% -$37.2K 0.02% 731
2015
Q1 		$561K Buy
8,574
+280
+3% +$18.6K 0.02% 739
2014
Q4 		$539K Buy
8,294
+359
+5% +$23.1K 0.02% 744
2014
Q3 		$477K Buy
7,935
+607
+8% +$39.7K 0.01% 854
2014
Q2 		$507K Buy
7,328
+413
+6% +$26.8K 0.02% 751
2014
Q1 		$452K Buy
6,915
+427
+7% +$27.8K 0.02% 756
2013
Q4 		$402K Buy
6,488
+335
+5% +$19.4K 0.02% 748
2013
Q3 		$330K Buy
6,153
+578
+10% +$29.8K 0.01% 797
2013
Q2 		$254K Buy
+5,575
New +$242K 0.01% 830

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Cambridge Investment Research Advisors's STJ Position: Q1 2017 in Review

Cambridge Investment Research Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 7,675 shares — an estimated $615K sold.

Cambridge Investment Research Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.46M in Q4 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Cambridge Investment Research Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 7,675 St Jude Medical shares in Q1 2017, an estimated $615K.
  • Cambridge Investment Research Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Cambridge Investment Research Advisors's St Jude Medical position peaked at $1.46M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2017, filed 12 May 2017.